Protalix BioTherapeutics (PLX) Gross Profit Growth (5y) (2015 - 2026)
Protalix BioTherapeutics (PLX) Gross Profit Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Protalix BioTherapeutics | 192.04 Mn | 181.24 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.21% |
| Dec 31, 2025 | -23.10% |
| Sep 30, 2025 | 3.76% |
| Jun 30, 2025 | 1.38% |
| Mar 31, 2025 | -36.15% |
| Dec 31, 2024 | 5.38% |
| Sep 30, 2024 | -2.79% |
| Jun 30, 2024 | -15.90% |
| Mar 31, 2024 | -32.85% |
| Dec 31, 2023 | 38.64% |
| Sep 30, 2023 | 44.72% |
| Jun 30, 2023 | 177.79% |
| Mar 31, 2023 | 31.90% |
| Dec 31, 2022 | 46.71% |
| Sep 30, 2022 | 37.24% |
| Jun 30, 2022 | 41.08% |
| Mar 31, 2022 | 65.85% |
| Dec 31, 2021 | 111.05% |
| Sep 30, 2021 | 81.67% |
| Jun 30, 2021 | 78.30% |